Gemcitabine plus selinexor in selective advanced sarcomas: a phase I of the Spanish group for research on sarcoma study

Journal:

Nature Communications

Published:

2026-01-20

DOI:

10.1038/s41467-026-68729-1

Affiliations:

13

Authors:

15

Go to article

Institutions	Authors	Share
Hospital Universitario Fundación Jiménez Díaz (FJD), UAM, Spain	3.333333	0.22
Health Research Institute of San Carlos (IdISSC), Spain	3.000000	0.20
La Paz University Hospital, UAM, Spain	2.000000	0.13
Hospital Universitari Son Espases, Spain	2.000000	0.13
Hospital Universitario General de Villalba, Spain	1.666667	0.11
Hospital Universitario Miguel Servet, Unizar, Spain	1.000000	0.07
Vall d'Hebron University Hospital (HUVH), ICS, Spain	1.000000	0.07
Sofpromed Investigación Clínica, SLU, Spain	1.000000	0.07

Interested in Oncology and Carcinogenesis?